Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Rotavirus Infections Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
UMN Pharma Inc
Nanotherapeutics Inc
Curevac AG
Wuhan Institute of Biological Products Co Ltd
Medicago Inc
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
Serum Institute of India Ltd
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
RV-3BB
RV-625
UMN-2001
Rotavac-5C
Others
Application:
Clinic
Hospital
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Rotavirus Infections Drug Industry Overview
-
1.1.1 Rotavirus Infections Drug Market Scope and Market Segments
-
1.1.2 Rotavirus Infections Drug Industry Characteristics
-
1.1.3 Global and China Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Rotavirus Infections Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Rotavirus Infections Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 RV-3BB
-
1.2.2 RV-625
-
1.2.3 UMN-2001
-
1.2.4 Rotavac-5C
-
1.2.5 Others
-
1.3 Global Rotavirus Infections Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Clinic
-
1.3.2 Hospital
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Rotavirus Infections Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Rotavirus Infections Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Rotavirus Infections Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Rotavirus Infections Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Rotavirus Infections Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Rotavirus Infections Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Rotavirus Infections Drug Industry PEST Analysis
-
2.3 Rotavirus Infections Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Rotavirus Infections Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Rotavirus Infections Drug Industry
Chapter 3 Global and China Rotavirus Infections Drug Market, by Manufacturer
-
3.1 Global and China Rotavirus Infections Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Rotavirus Infections Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Rotavirus Infections Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Rotavirus Infections Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Rotavirus Infections Drug Market Top 3 Players
Chapter 4 Global and China Rotavirus Infections Drug Market, by Type (2017-2028)
-
4.1 Rotavirus Infections Drug Market Trend, by Type
-
4.2 Global Rotavirus Infections Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Rotavirus Infections Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Rotavirus Infections Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Rotavirus Infections Drug Price Trend, by Type (2017-2028)
-
4.3 China Rotavirus Infections Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Rotavirus Infections Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Rotavirus Infections Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Rotavirus Infections Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Rotavirus Infections Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Rotavirus Infections Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Rotavirus Infections Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Rotavirus Infections Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Rotavirus Infections Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Rotavirus Infections Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Rotavirus Infections Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Rotavirus Infections Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Rotavirus Infections Drug Market Analysis
-
7.1 North America Rotavirus Infections Drug Market, by Type
-
7.2 North America Rotavirus Infections Drug Market, by Application
-
7.3 North America Rotavirus Infections Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Rotavirus Infections Drug Market Analysis
-
8.1 Europe Rotavirus Infections Drug Market, by Type
-
8.2 Europe Rotavirus Infections Drug Market, by Application
-
8.3 Europe Rotavirus Infections Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Rotavirus Infections Drug Market Analysis
-
9.1 APAC Rotavirus Infections Drug Market, by Type
-
9.2 APAC Rotavirus Infections Drug Market, by Application
-
9.3 APAC Rotavirus Infections Drug Market Analysis and Forecast, by Country
-
9.3.1 China Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Rotavirus Infections Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Rotavirus Infections Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Rotavirus Infections Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Rotavirus Infections Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Rotavirus Infections Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Rotavirus Infections Drug Company Profiles
-
11.1 UMN Pharma Inc
-
11.1.1 UMN Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 UMN Pharma Inc Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.1.3 UMN Pharma Inc Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Nanotherapeutics Inc
-
11.2.1 Nanotherapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Nanotherapeutics Inc Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.2.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Curevac AG
-
11.3.1 Curevac AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Curevac AG Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.3.3 Curevac AG Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Wuhan Institute of Biological Products Co Ltd
-
11.4.1 Wuhan Institute of Biological Products Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.4.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Medicago Inc
-
11.5.1 Medicago Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Medicago Inc Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.5.3 Medicago Inc Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Beijing Minhai Biotechnology Co Ltd
-
11.6.1 Beijing Minhai Biotechnology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.6.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Bharat Biotech International Ltd
-
11.7.1 Bharat Biotech International Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Bharat Biotech International Ltd Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.7.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Biological E Ltd
-
11.8.1 Biological E Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Biological E Ltd Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.8.3 Biological E Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Serum Institute of India Ltd
-
11.9.1 Serum Institute of India Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Serum Institute of India Ltd Rotavirus Infections Drug Product Profiles, Application and Specification
-
11.9.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Rotavirus Infections Drug Industry Investment Prospect and Risk Assessment
-
12.1 Rotavirus Infections Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Rotavirus Infections Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Rotavirus Infections Drug Production Value and Growth Rate (2017-2028)
-
Figure China Rotavirus Infections Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of RV-3BB (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of RV-625 (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of UMN-2001 (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of Rotavac-5C (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Rotavirus Infections Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Rotavirus Infections Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Rotavirus Infections Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Rotavirus Infections Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Rotavirus Infections Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Rotavirus Infections Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Rotavirus Infections Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Rotavirus Infections Drug Market Share, by Manufacturer in 2022
-
Table Global Rotavirus Infections Drug Sales Volume, by Type (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Value, by Type (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Rotavirus Infections Drug Price Trend, by Type (2017-2028)
-
Table China Rotavirus Infections Drug Sales Volume, by Type (2017-2028)
-
Table China Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Table China Rotavirus Infections Drug Sales Value, by Type (2017-2028)
-
Table China Rotavirus Infections Drug Sales Value Share, by Type (2017-2028)
-
Figure China Rotavirus Infections Drug Price Trend, by Type (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Volume, by Application (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Value, by Application (2017-2028)
-
Table Global Rotavirus Infections Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Rotavirus Infections Drug Sales Value Share, by Application (2017-2028)
-
Table China Rotavirus Infections Drug Sales Volume, by Application (2017-2028)
-
Table China Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Table China Rotavirus Infections Drug Sales Value, by Application (2017-2028)
-
Table China Rotavirus Infections Drug Sales Value Share, by Application (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Value Share, by Application (2017-2028)
-
Figure China Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Rotavirus Infections Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Rotavirus Infections Drug Sales Volume, by Type (2017-2028)
-
Table North America Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Rotavirus Infections Drug Sales Volume, by Application (2017-2028)
-
Table North America Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Rotavirus Infections Drug Sales Volume, by Type (2017-2028)
-
Table Europe Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Rotavirus Infections Drug Sales Volume, by Application (2017-2028)
-
Table Europe Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Rotavirus Infections Drug Sales Volume, by Type (2017-2028)
-
Table APAC Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Rotavirus Infections Drug Sales Volume, by Application (2017-2028)
-
Table APAC Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Rotavirus Infections Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Rotavirus Infections Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Rotavirus Infections Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Rotavirus Infections Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Rotavirus Infections Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Rotavirus Infections Drug Sales Value and Growth Rate (2017-2028)
-
Table UMN Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UMN Pharma Inc Product Profiles, Application and Specification
-
Table UMN Pharma Inc Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Nanotherapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Nanotherapeutics Inc Product Profiles, Application and Specification
-
Table Nanotherapeutics Inc Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Curevac AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Curevac AG Product Profiles, Application and Specification
-
Table Curevac AG Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Wuhan Institute of Biological Products Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Wuhan Institute of Biological Products Co Ltd Product Profiles, Application and Specification
-
Table Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Medicago Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Medicago Inc Product Profiles, Application and Specification
-
Table Medicago Inc Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Beijing Minhai Biotechnology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beijing Minhai Biotechnology Co Ltd Product Profiles, Application and Specification
-
Table Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bharat Biotech International Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bharat Biotech International Ltd Product Profiles, Application and Specification
-
Table Bharat Biotech International Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biological E Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biological E Ltd Product Profiles, Application and Specification
-
Table Biological E Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Serum Institute of India Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Serum Institute of India Ltd Product Profiles, Application and Specification
-
Table Serum Institute of India Ltd Rotavirus Infections Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
